摘要
丙型肝炎(hepatitis C,HC)是一种发病率高、病死率高的传染病,全球约1.8亿人感染丙型肝炎病毒(hepatitis C virus,HCV),至今无法治愈。本文概述了近几年来抗HCV药物,包括干扰素及利巴韦林、特殊靶向治疗药物和免疫调节剂等的研究进展。
Hepatitis C（HC） is a communicable disease with high morbidity and high mortality.Approximately 180 million people are infected with hepatitis C virus （HCV） across the globe,however,there is still no effective treatment.This review gives an outline of the research advances in anti-HCV drugs,including interferon combined with ribavirin,specific targeted therapy drugs,immune modulators and so on.
出处
《药学服务与研究》
CAS
CSCD
2013年第5期361-364,共4页
Pharmaceutical Care and Research
关键词
肝炎病毒
丙型
抗病毒药
综述
hepatitis C virus
antiviral agents
review
